12
Total investments
0
Early stage
7
Mid stage
2
Late stage
6y
Years active
Portfolio
11 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor, Board Observer
Sep 2024
Prolific Machines is ushering in a new era of biotechnology with light. We harness light to produce everyday essentials more efficiently, from food and lifesaving drugs to novel biosolutions. Our first-of-its-kind photomolecular biology platform delivers unprecedented control, precisely guiding cellular behavior when and where it matters most. Unlike existing tools used to control biology, our technology unlocks dynamic control over virtually any cellular function in any cell type. We are enabling partners to unlock robust efficiency, quality, reproducibility, and sustainability advantages across pharmaceuticals, nutritional and therapeutic proteins, cellular agriculture, and more. To learn more, visit prolific-machines.com. Contact partners@prolific-machines.com to co-develop the future of biology.
Investor, Board Observer
Aug 2024
We work to map the microbiome and illuminate interactions foundational to the health of humanity.
Investor, Board Observer
Aug 2024
Cyclarity Therapeutics, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.
Vice President, Venture Investments
Aug 2024
Fonterra Cooperative Group is the worlds largest exporter of dairy products, a leader in dairy science and innovation, and a partner to many of the worlds leading food companies.
Fonterra is headquartered in New Zealand, with offices in more than 40 countries around the world.
Investor, Board Observer
Dec 2022
Andes empowers biology to enable positive action against climate change.
Investor, Board Observer
Nov 2022
A Grão Direto conecta produtores rurais e compradores de grãos de forma mais eficiente, segura e moderna, através de uma plataforma digital. Atualmente, já são centenas de milhares de toneladas de soja, milho e sorgo, negociadas digitalmente, tanto no mercado físico, quanto no mercado a termo (travamentos futuros) e barter (permuta). Baixe gratuitamente o aplicativo da Grão Direto e tenha acesso as melhores informações, para você tomar as melhores decisões. Vantagens para quem vende, muito mais vantagens para quem compra!
Conheça mais sobre a Grão Direto pelo aplicativo: bit.ly/GraoDiretoAPP
Investor, Board Observer
Jun 2022
Founded in 2017, Nori is on a mission to scale carbon removal, with the ultimate goal of reversing climate change.
Our fully integrated carbon removal issuing program, registry, and marketplace simplifies a complicated market, increasing transparency, trust, efficiency, and impact for buyers and sellers alike.
We make it easy for businesses to drive positive climate impact by giving them access to verified carbon removal credits that support regenerative farmers in the US, help scale the technology underpinning promising durable solutions, and can be integrated directly into products.
For suppliers, we streamline the process of developing, verifying, and selling carbon removal credits, so that they can focus on what they do best — removing carbon from the atmosphere.
We also engage with federal agencies and policymakers to advocate for supplier-enabling policies and consistent definitions and standards that help inspire confidence in the market.
Collectively, we have to remove between 5 and 10 billion tonnes of carbon dioxide from the atmosphere each year to reach global climate mitigation targets – and even more to drive climate change in reverse. Nori enables everyone to participate with confidence because every tonne counts.
Investor
Feb 2022
Wildtype isn’t plant-based, farmed-raised, or wild-caught. Were making cultivated seafood, starting with sushi-grade salmon.
Investor
Sep 2021
Regrow Ag powers agriculture resilience for today’s leading retailers, CPGs, processors, and farmers.
Regrow’s Agriculture Resilience Platform gives companies across the ag supply chain the ability to assure their supply chains and protect operational integrity by accelerating the needed scale of GHG emissions reduction, adoption of regenerative farming practices, and proactive adaptation to the changing climate.
Recently named one of the TIME100 Most Influential Companies of 2023, Regrow’s rapidly growing list of partners includes Cargill, General Mills, and Kellanova.
Regrow earned the standing of No. 41 on Fast Company’s list of the World’s 50 Most Innovative Companies in 2023 and was named the No. 1 Most Innovative Company in Agriculture.
Investor, Board Observer
Jul 2021
Since 2016, AnimalBiome has helped tens of thousands of pet parents and veterinarians monitor and improve the gut health, and overall health, of companion animals around the world. See how we can help your pet or veterinary practice at animalbiome.com or animalbiome.vet (veterinarians only).
Investor
2020
Leaps by Bayer invests in paradigm-shifting advances in the life sciences – targeting the breakthroughs that could fundamentally change the world for the better. Our approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity. Leaps aims to conquer ten huge challenges in the areas of health and agriculture. Some people call them impossible. We call them “leaps.”
Experience · 14 entries
All (14)
Investments (12)
Board (8)
2025
Investor, Board Observer
Jan 2025
BioLumic is a pioneer in plant trait development. We program the genetic expression of plants with light to unlock their natural potential without chemicals or genetic modification. Our novel xTraits(TM) activate untapped biological mechanisms in seeds and seedlings, enhancing yield, vigor, nutrition, and health.
With expertise across 12+ crops—including corn, soybean, rice, and forage—BioLumic offers a proprietary solution that brings crop traits to market 90% faster and lower cost. We are dedicated to advancing agriculture by fostering crop equity and resilience while minimizing environmental impact along the value chain.
2024
Investor, Board Observer
Sep 2024
Prolific Machines is ushering in a new era of biotechnology with light. We harness light to produce everyday essentials more efficiently, from food and lifesaving drugs to novel biosolutions. Our first-of-its-kind photomolecular biology platform delivers unprecedented control, precisely guiding cellular behavior when and where it matters most. Unlike existing tools used to control biology, our technology unlocks dynamic control over virtually any cellular function in any cell type. We are enabling partners to unlock robust efficiency, quality, reproducibility, and sustainability advantages across pharmaceuticals, nutritional and therapeutic proteins, cellular agriculture, and more. To learn more, visit prolific-machines.com. Contact partners@prolific-machines.com to co-develop the future of biology.
Head of North America Investing
Aug 2024
At Ki Tua Fund, we invest in, partner, and work with extraordinary founders and start-ups, to accelerate and scale disruptive solutions together. Combining science, nutrition, and technology to make a positive impact on health. Connect with us and ignite innovation.
Investor, Board Observer
Aug 2024
We work to map the microbiome and illuminate interactions foundational to the health of humanity.
Investor, Board Observer
Aug 2024
Cyclarity Therapeutics, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.
Show all 14 entries ↓
Investment activity
2020–2025 · 12 investments
Recent (last 2 years)Earlier
